Thrombopoietin receptor agonists as an emergency treatment for severe newly diagnosed immune thrombocytopenia in children

MLA

Helder Fernandes, et al. Thrombopoietin Receptor Agonists as an Emergency Treatment for Severe Newly Diagnosed Immune Thrombocytopenia in Children. Jan. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....959a85e3f68291a944965a43300083c3&authtype=sso&custid=ns315887.

APA

Helder Fernandes, Guy Leverger, Marlène Pasquet, Thierry Leblanc, Stéphane Ducassou, Joy Benadiba, Eric Jeziorski, Marie Nolla, Nathalie Aladjidi, Marc Michel, Corinne Pondarré, Mony Fahd, Vincent Barlogis, & Pascale Blouin. (2021). Thrombopoietin receptor agonists as an emergency treatment for severe newly diagnosed immune thrombocytopenia in children.

Chicago

Helder Fernandes, Guy Leverger, Marlène Pasquet, Thierry Leblanc, Stéphane Ducassou, Joy Benadiba, Eric Jeziorski, et al. 2021. “Thrombopoietin Receptor Agonists as an Emergency Treatment for Severe Newly Diagnosed Immune Thrombocytopenia in Children,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....959a85e3f68291a944965a43300083c3&authtype=sso&custid=ns315887.